{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:17:18Z","timestamp":1783156638276,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13550-018-0447-8","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T08:18:18Z","timestamp":1538727498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?"],"prefix":"10.1186","volume":"8","author":[{"given":"Sho","family":"Furuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-8441","authenticated-orcid":false,"given":"Osamu","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Koyanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"447_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13550-017-0315-y","volume":"7","author":"M Ishiyama","year":"2017","unstructured":"Ishiyama M, Soine LA, Vesselle HJ. Semi-quantitative metabolic values on FDG PET\/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis. EJNMMI Res. 2017;7:67.","journal-title":"EJNMMI Res"},{"key":"447_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2466-12-57","volume":"12","author":"RL Mostard","year":"2012","unstructured":"Mostard RL, Van Kuijk SM, Verschakelen JA, et al. A predictive tool for an effective use of F18-FDG PET in assessing activity of sarcoidosis. BMC Pulm Med. 2012;12:57.","journal-title":"BMC Pulm Med"},{"key":"447_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","volume":"105","author":"RL Mostard","year":"2011","unstructured":"Mostard RL, Voo S, van Kroonenburgh MJ, et al. Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis. Respir Med. 2011;105:1917\u201324.","journal-title":"Respir Med"},{"key":"447_CR4","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","volume":"38","author":"H Ohira","year":"2011","unstructured":"Ohira H, Tsujino I, Yoshinaga K. (1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38:1773\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"447_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","volume":"63","author":"R Blankstein","year":"2014","unstructured":"Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"447_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.17996\/anc.17-00015","volume":"3","author":"O Manabe","year":"2017","unstructured":"Manabe O, Ohira H, Yoshinaga K, Naya M, Oyama-Manabe N, Tamaki N. Qualitative and quantitative assessments of cardiac sarcoidosis using 18F-FDG PET. Ann Nucl Cardiol. 2017;3:117\u201320.","journal-title":"Ann Nucl Cardiol"},{"issue":"Suppl 1","key":"447_CR7","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S\u201350S.","journal-title":"J Nucl Med"},{"key":"447_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","volume":"21","author":"A Ahmadian","year":"2014","unstructured":"Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925\u201339.","journal-title":"J Nucl Cardiol"},{"key":"447_CR9","doi-asserted-by":"publisher","first-page":"e105682","DOI":"10.1371\/journal.pone.0105682","volume":"9","author":"K Hirata","year":"2014","unstructured":"Hirata K, Kobayashi K, Wong KP, et al. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS One. 2014;9:e105682.","journal-title":"PLoS One"},{"key":"447_CR10","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00259-015-3074-x","volume":"42","author":"BA Blomberg","year":"2015","unstructured":"Blomberg BA, Bashyam A, Ramachandran A, et al. Quantifying [(1)(8)F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction. Eur J Nucl Med Mol Imaging. 2015;42:1414\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"O Manabe","year":"2016","unstructured":"Manabe O, Yoshinaga K, Ohira H, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23:244\u201352.","journal-title":"J Nucl Cardiol"},{"key":"447_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","volume":"28","author":"Y Ishida","year":"2014","unstructured":"Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393\u2013403.","journal-title":"Ann Nucl Med"},{"key":"447_CR13","doi-asserted-by":"publisher","unstructured":"Manabe O, Kroenke M, Aikawa T, et al. Volume-based glucose metabolic analysis of FDG PET\/CT: The optimum threshold and conditions to suppress physiological myocardial uptake. J Nucl Cardiol. 2017.\u00a0\n                    https:\/\/doi.org\/10.1007\/s12350-017-1122-6\n                    \n                  .","DOI":"10.1007\/s12350-017-1122-6"},{"key":"447_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s12350-013-9798-8","volume":"20","author":"LC Gormsen","year":"2013","unstructured":"Gormsen LC, Christensen NL, Bendstrup E, Tolbod LP, Nielsen SS. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:1108\u201315.","journal-title":"J Nucl Cardiol"},{"key":"447_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/10253890.2015.1067677","volume":"18","author":"A Siddiqui","year":"2015","unstructured":"Siddiqui A, Madhu SV, Sharma SB, Desai NG. Endocrine stress responses and risk of type 2 diabetes mellitus. Stress. 2015;18:498\u2013506.","journal-title":"Stress"},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajpath.2016.11.009","volume":"187","author":"SJ Burke","year":"2017","unstructured":"Burke SJ, Batdorf HM, Eder AE, et al. Oral corticosterone administration reduces insulitis but promotes insulin resistance and hyperglycemia in male nonobese diabetic mice. Am J Pathol. 2017;187:614\u201326.","journal-title":"Am J Pathol"},{"key":"447_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014;30:96\u2013102.","journal-title":"Diabetes Metab Res Rev"},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biochi.2004.12.005","volume":"87","author":"T Cadoudal","year":"2005","unstructured":"Cadoudal T, Leroyer S, Reis AF, et al. Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome. Biochimie. 2005;87:27\u201332.","journal-title":"Biochimie"},{"key":"447_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1104\/pp.103.036962","volume":"135","author":"T Taybi","year":"2004","unstructured":"Taybi T, Nimmo HG, Borland AM. Expression of phosphoenolpyruvate carboxylase and phosphoenolpyruvate carboxylase kinase genes. Implications for genotypic capacity and phenotypic plasticity in the expression of crassulacean acid metabolism. Plant Physiol. 2004;135:587\u201398.","journal-title":"Plant Physiol"},{"key":"447_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11307-009-0258-4","volume":"12","author":"GG Bural","year":"2010","unstructured":"Bural GG, Torigian DA, Burke A, et al. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol. 2010;12:233\u20139.","journal-title":"Mol Imaging Biol"},{"key":"447_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.metabol.2008.05.015","volume":"57","author":"R Borra","year":"2008","unstructured":"Borra R, Lautamaki R, Parkkola R, et al. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism. 2008;57:1445\u201351.","journal-title":"Metabolism"},{"key":"447_CR22","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00261-017-1049-z","volume":"42","author":"JK Jang","year":"2017","unstructured":"Jang JK, Jang HJ, Kim JS, Kim TK. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol (NY). 2017;42:1667\u201378.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"447_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2214\/ajr.149.3.491","volume":"149","author":"J Yoshikawa","year":"1987","unstructured":"Yoshikawa J, Matsui O, Takashima T, et al. Focal fatty change of the liver adjacent to the falciform ligament: CT and sonographic findings in five surgically confirmed cases. AJR Am J Roentgenol. 1987;149(3):491\u20134.","journal-title":"AJR Am J Roentgenol"},{"key":"447_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00125-006-0560-5","volume":"50","author":"T Cadoudal","year":"2007","unstructured":"Cadoudal T, Blouin JM, Collinet M, et al. Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia. 2007;50:666\u201375.","journal-title":"Diabetologia"},{"issue":"5","key":"447_CR25","first-page":"682","volume":"44","author":"P Iozzo","year":"2003","unstructured":"Iozzo P, Geisler F, Oikonen V, et al. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study. J Nucl Med. 2003;44(5):682\u20139.","journal-title":"J Nucl Med"},{"key":"447_CR26","doi-asserted-by":"crossref","unstructured":"Keramida G, Hunter J, Peters AM. Hepatic glucose utilisation in hepatic steatosis and obesity. Biosci Rep. 2016;36(6).","DOI":"10.1042\/BSR20160381"},{"issue":"6","key":"447_CR27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116(6):1494\u2013505.","journal-title":"J Clin Invest"},{"key":"447_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1600-6143.2004.00432.x","volume":"4","author":"A Burke","year":"2004","unstructured":"Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant. 2004;4:686\u201393.","journal-title":"Am J Transplant"},{"key":"447_CR29","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut"},{"key":"447_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265\u20139.","journal-title":"Gut"},{"key":"447_CR31","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1007\/s00261-017-1166-8","volume":"42","author":"AM Ahmed","year":"2017","unstructured":"Ahmed AM, Ebid ME, Ajlan AM, Al-Mallah MH. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdom Radiol (NY). 2017;42:2454\u20139.","journal-title":"Abdom Radiol (NY)"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-018-0447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-018-0447-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-018-0447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:05:23Z","timestamp":1570215923000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-018-0447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1186\/s13550-018-0447-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures in studies involving humans were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Hokkaido University Hospital is the local ethics committee that reviewed and approved the protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}